Listed by the USPTO as DICKENS, AMELIA NICOLE
Tech Center 1600 • Art Units: 1644 1645 1671
This examiner grants 47% of resolved cases
DICKENS, AMELIA NICOLE has resolved 127 cases in Tech Center 1600 and Art Unit 1644. The allowance rate is 47.2%, and the median time to allowance is 1276 days. The interview lift is 21.6%, indicating a positive association between interviews and allowance within the recorded matters.
The recorded companies are Intervet Inc., CJ CheilJedang Corporation, and Kaneka Corporation. The listed firms are Barnes & Thornburg LLP (IN), Morgan, Lewis & Bockius LLP (WA), and SUGHRUE MION, PLLC. The smaller resolved-case record calls for measured use of the profile, but the timing and interview measures still provide practical points for prosecution planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18852236 | COMPOSITION CONTAINING BACILLUS AMYLOLIQUEFACIENS STRAIN FOR ENHANCING PLANT DISEASE RESISTANCE AND USE THEREOF | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18466984 | METHOD FOR PRODUCING FOREIGN PROTEIN USING E. COLI | Non-Final OA | KANEKA CORPORATION |
| 18016432 | RECOMBINANT MICROORGANISMS | Non-Final OA | The Regents of the University of California |
| 18574816 | BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISMS, COMPOSITIONS AND USES THEREOF | Non-Final OA | Société des Produits Nestlé S.A. |
| 18292542 | VACCINE COMPOSITIONS COMPRISING BRUCELLA STRAINS AND METHODS THEREOF | Final Rejection | THE TEXAS A&M UNIVERSITY SYSTEM |
| 18488471 | METHYLOBACTERIUM STRAINS FOR CONTROLLING CORN ROOTWORM | Final Rejection | NewLeaf Symbiotics, Inc. |
| 17788224 | PROCESS TO IDENTIFY CONSORTIA OF PROBIOTIC STRAINS SUITABLE FOR GLUTEN DEGRADATION | Final Rejection | Evonik Operations GmbH |
| 17335578 | METHODS FOR ASSESSING EFFICACY OF A DRUG IN VIVO BY MONITORING ADME PROTEINS IN EXTRACELLULAR VESICLES | Final Rejection | Purdue Research Foundation |
| 18690364 | METHOD AND COMPOSITION FOR REDUCING OR PREVENTING FIRE BLIGHT DISEASE IN A POME FRUIT TREE | Final Rejection | The Penn State Research Foundation |
| 18286005 | ENCAPSULATED MICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME | Final Rejection | Monsanto Technology LLC |
| 18167664 | Microbially Induced Inflammation Produces Changes in Distinct Healthy Tissues in Human Oral Cavity | Final Rejection | Colgate-Palmolive Company |
| 18266167 | COMPOSITION COMPRISING BACTERIUM OF THE GENUS ACIDIPROPIONIBACTERIUM OR PROCESSED PRODUCT THEREOF | Non-Final OA | MEIJI CO., LTD. |
| 17775425 | A NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS | Non-Final OA | Intervet Inc. |
| 17775428 | NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS | Non-Final OA | Intervet Inc. |
| 18328308 | ANTAGONIST MICROORGANISMS FOR INHIBITING FIRE BLIGHT AND COMPOSITION FOR INHIBITING FIRE BLIGHT WITH THE SAME AS ACTIVE INGREDIENT | Non-Final OA | KNU-INDUSTRY COOPERATION FOUNDATION |
| 18824806 | METHODS FOR DETERMINING ANTIBIOTIC SENSITIVITY | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy47.2% of resolved applications examined by Amelia Nicole Dickens were allowed (127 resolved cases), compared with 35.9% across Art Unit 1644 over the last five years.
This examiner's interview lift is +21.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Amelia Nicole Dickens took 1,276 days on average from filing to allowance.
Amelia Nicole Dickens examines applications in Art Unit 1644 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
